Metformin displayed a lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had the highest risk.
1999 to mid-2000s saw increase in seniors using prescription meds
Jul 09, 2024
Polypharmacy increased, peaking at 43.0% in 2017 to March 2020; hyperpolypharmacy increased during 1999-2000 to 2007-2008.
Mean cost of bringing new drug to US market Is $879.3 million
Jul 02, 2024
R&D has remained relatively stable among large pharma companies despite a 27.3% growth in sales.
Medically advised aspirin use lower in 2021 than 2012 to 2017
Jun 24, 2024
Compared with 2012 to 2017, in 2021, medically advised aspirin use for primary prevention was lower (19.3 versus 27.6 to 31.2% among adults aged 60 to 69 years; 30.6 versus 38.35 to 41.6% among those aged...
Fewer adults eligible for statins with PREVENT equations
Jun 21, 2024
Compared with the pooled cohort equations, the mean estimated 10-year ASCVD risk was lower using the PREVENT equations across all age, sex and racial subgroups, with the largest difference seen for Black...